Valneva SE (LON:0OB3)
London · Delayed Price · Currency is GBP · Price in EUR 4.390
+0.298 (7.29%)
Feb 12, 2026, 4:37 PM GMT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of 657.82 million as of February 12, 2026. Its market cap has increased by 84.47% in one year.
Market Cap
657.82M
Enterprise Value
703.45M
Revenue
157.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.39
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 66.74M to 657.82M, an increase of 885.68%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 657.82M | 17.40% |
| Dec 31, 2025 | 560.34M | 92.99% |
| Dec 31, 2024 | 290.35M | -48.92% |
| Dec 29, 2023 | 568.46M | -25.57% |
| Dec 30, 2022 | 763.80M | -64.68% |
| Dec 31, 2021 | 2.16B | 242.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Biomedica | 998.08M |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |
| Allergy Therapeutics | 718.55M |